shro

Honoring Dedication: Dr. Antonio Giordano Presents the Leonardo da Vinci Award to Dr. Monica M. Bertagnolli at NIAF’s 49th Anniversary Gala

Dr. Antonio Giordano Presents the Leonardo da Vinci Award to Dr. Monica M. Bertagnolli at NIAF’s 49th Anniversary Gala

In a warm and elegant celebration at the 49th anniversary gala of the National Italian American Foundation (NIAF) in Washington, D.C., Dr. Antonio Giordano, President of the Sbarro Health Research Organization and Professor at Temple University, presented the prestigious Leonardo da Vinci Award for Health and Science to Dr. Monica M. Bertagnolli. Dr. Bertagnolli, the 17th Director of the National Institutes of Health (NIH), has become a beacon of inspiration as the first surgeon and only the second woman to lead one of the world’s most influential health institutions.

 

Dr. Bertagnolli’s life work is one of unyielding dedication to cancer research and patient advocacy. For years, she has been at the forefront of oncology, not only understanding cancer but also advancing ways to treat it, providing hope and care to countless individuals and families. Before taking on her role as NIH Director, Dr. Bertagnolli led the National Cancer Institute and held pivotal positions at renowned institutions such as Harvard Medical School, the Dana-Farber Cancer Institute, the American Society of Clinical Oncology, and the American Cancer Society. Her contributions in these roles have been vital in transforming cancer care and research on a global scale.

 

This award from NIAF reflects the deep respect and admiration the Italian-American community holds for Dr. Bertagnolli’s achievements. The Leonardo da Vinci Award, named after one of history’s greatest thinkers, symbolizes the power of knowledge, innovation, and the pursuit of better health—a mission Dr. Bertagnolli embodies.

 

The evening’s celebration was made even more special with the presence of Miguel Mostafa, Dean of the College of Science and Technology at Temple University and a close ally of Dr. Giordano’s Sbarro Health Research Organization. Together, these leaders continue to shape the future of science and health, united by their commitment to pushing boundaries and nurturing hope.

 

Dr. Bertagnolli’s recognition at the gala is a reminder of the enduring impact one individual can make and the power of community in supporting those who strive to make the world healthier.

Professor Antonio Giordano, M.D., Ph.D., is the creator and head of the Sbarro Health Research Organization, located at Temple University‘s College of Science and Technology in Philadelphia. Stay connected with him through his various social media platforms, including Facebook, LinkedIn, Twitter, and Instagram, to receive the latest updates.
What is it about? Why is it important piece in the fight against cancer?

The result obtained are important data: the study demonstrated how the lack of a Cdk9 protein negatively impacts DNA repair processes. Alterations in this process are therefore responsible for the development of various tumour pathologies for which the discovery opens up new scenarios for the identification of precision drugs.